Literature DB >> 3179938

Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors.

H L Evans1, S P Chawla, C Simpson, K P Finn.   

Abstract

Thirty-seven cases of uterine leiomyosarcoma are presented, along with nine cases of leiomyoma variants from which they were distinguished. All patients were followed for a minimum of 10 years. In cases with nuclear pleomorphism, leiomyosarcoma was diagnosed when there were five or more mitotic figures in ten consecutive high-power (X400) fields in the most active area of the tumor, and also when there were fewer mitotic figures but extensive tumor necrosis (there was only one leiomyosarcoma without nuclear pleomorphism, and it had more than 20 mitotic figures in ten high-power fields). Tumor size was the major prognostic factor in the leiomyosarcoma group; five of eight patients with neoplasms measuring less than 5 cm in maximum dimension survived, whereas no patient with a larger tumor did so. Other pathologic and clinical variables, including mitotic rate, tumor necrosis, degree of nuclear pleomorphism, vascular invasion, and patient age, had no significant relationship to survival or tumor behavior in leiomyosarcoma when tumor size was taken into account. The nine cases of leiomyoma variants consisted of three atypical leiomyomas (which had nuclear pleomorphism, one or no mitotic figures per ten high-power fields, and no necrosis), two plexiform leiomyomas, two cases of peritoneal leiomyomatosis, one palisaded leiomyoma, and one case of intravenous leiomyomatosis; all of these patients were tumor-free on follow-up.

Entities:  

Mesh:

Year:  1988        PMID: 3179938     DOI: 10.1002/1097-0142(19881115)62:10<2239::aid-cncr2820621028>3.0.co;2-y

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  A rare case of uterine leiomyosarcoma: a case report.

Authors:  Venkata Sujatha Vellanki; Meghana Rao; Chinna Babu Sunkavalli; Rao N Chinamotu; Shailaja Kaja
Journal:  J Med Case Rep       Date:  2010-07-22

Review 2.  A review of treatment of uterine leiomyosarcomas.

Authors:  Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

3.  A Case of Renal Metastasis of Uterine Leiomyosarcoma.

Authors:  Petar Bajic; William S Gange; Robert H Blackwell; Arpeet S Shah; John Biemer; Maria M Picken; Alex Gorbonos
Journal:  Cureus       Date:  2017-07-14

4.  Epithelioid leiomyosarcoma of uterus.

Authors:  Aparna Setia; Shalini Kanotra; Ritika Aggarwal; Dilip Prabhakarrao Bhavthankar
Journal:  BMJ Case Rep       Date:  2012-04-02

Review 5.  Gastrointestinal (GI) leiomyosarcoma (LMS) case series and review on diagnosis, management, and prognosis.

Authors:  Lara Hilal; Kassem Barada; Deborah Mukherji; Sally Temraz; Ali Shamseddine
Journal:  Med Oncol       Date:  2016-01-20       Impact factor: 3.064

6.  Atypical uterine leiomyoma: a rare variant of a common problem.

Authors:  Homa Hosseini; Yves Jacquemyn; Kathleen Goossens; Veerle Van Marck
Journal:  BMJ Case Rep       Date:  2009-06-01

7.  A primary leiomyosarcoma of bone containing pseudoepithelial plexiform elements.

Authors:  A Rigopoulou; M Vlychou; S J Ostlere; C L M H Gibbons; N A Athanasou
Journal:  Skeletal Radiol       Date:  2007-05-05       Impact factor: 2.199

Review 8.  Uterine sarcoma 2008.

Authors:  Jeff F Lin; Brian M Slomovitz
Journal:  Curr Oncol Rep       Date:  2008-11       Impact factor: 5.075

9.  Global dysregulation of the chromosome 14q32 imprinted region in uterine carcinosarcoma.

Authors:  Eric J Devor; Jillian N DE Mik; Shyam Ramachandran; Michael J Goodheart; Kimberly K Leslie
Journal:  Exp Ther Med       Date:  2012-01-25       Impact factor: 2.447

10.  Molecular and cytogenetic characterization of plexiform leiomyomata provide further evidence for genetic heterogeneity underlying uterine fibroids.

Authors:  Jennelle C Hodge; Bradley J Quade; Mark A Rubin; Elizabeth A Stewart; Paola Dal Cin; Cynthia C Morton
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.